Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive factors for long-term engraftment of autologous blood stem cells.
Duggan PR, Guo D, Luider J, Auer I, Klassen J, Chaudhry A, Morris D, Glück S, Brown CB, Russell JA, Stewart DA. Duggan PR, et al. Among authors: stewart da. Bone Marrow Transplant. 2000 Dec;26(12):1299-304. doi: 10.1038/sj.bmt.1702708. Bone Marrow Transplant. 2000. PMID: 11223969
Storage of blood for in vitro generation of dendritic cells.
Syme R, Callaghan D, Duggan P, Bitner S, Kelly M, Wolff J, Stewart D, Glück S. Syme R, et al. Among authors: stewart d. Cytotherapy. 2002;4(3):271-6. doi: 10.1080/146532402320219781. Cytotherapy. 2002. PMID: 12194723
Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes.
Russell JA, Tran HT, Quinlan D, Chaudhry A, Duggan P, Brown C, Stewart D, Ruether JD, Morris D, Glick S, Gyonyor E, Andersson BS. Russell JA, et al. Among authors: stewart d. Biol Blood Marrow Transplant. 2002;8(9):468-76. doi: 10.1053/bbmt.2002.v8.pm12374451. Biol Blood Marrow Transplant. 2002. PMID: 12374451 Free article. Clinical Trial.
High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen.
Geddes M, Kangarloo SB, Naveed F, Quinlan D, Chaudhry MA, Stewart D, Savoie ML, Bahlis NJ, Brown C, Storek J, Andersson BS, Russell JA. Geddes M, et al. Among authors: stewart d. Biol Blood Marrow Transplant. 2008 Feb;14(2):220-8. doi: 10.1016/j.bbmt.2007.10.028. Biol Blood Marrow Transplant. 2008. PMID: 18215782 Free article. Clinical Trial.
Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease.
Russell JA, Duan Q, Chaudhry MA, Savoie ML, Balogh A, Turner AR, Larratt L, Storek J, Bahlis NJ, Brown CB, Quinlan D, Geddes M, Zacarias N, Daly A, Duggan P, Stewart DA. Russell JA, et al. Among authors: stewart da. Biol Blood Marrow Transplant. 2008 Aug;14(8):888-95. doi: 10.1016/j.bbmt.2008.05.010. Biol Blood Marrow Transplant. 2008. PMID: 18640572 Free article. Clinical Trial.
4,600 results